DK1503987T3 - Fremstilling af en vandfri quinolinbaseret CETP inhibitor ved krystallisering - Google Patents

Fremstilling af en vandfri quinolinbaseret CETP inhibitor ved krystallisering

Info

Publication number
DK1503987T3
DK1503987T3 DK02760459T DK02760459T DK1503987T3 DK 1503987 T3 DK1503987 T3 DK 1503987T3 DK 02760459 T DK02760459 T DK 02760459T DK 02760459 T DK02760459 T DK 02760459T DK 1503987 T3 DK1503987 T3 DK 1503987T3
Authority
DK
Denmark
Prior art keywords
crystallization
preparation
cetp inhibitor
anhydrous quinoline
based cetp
Prior art date
Application number
DK02760459T
Other languages
English (en)
Inventor
Peter Robert Rose
Susan Lee Orrill
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1503987T3 publication Critical patent/DK1503987T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK02760459T 2001-09-28 2002-08-22 Fremstilling af en vandfri quinolinbaseret CETP inhibitor ved krystallisering DK1503987T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32592601P 2001-09-28 2001-09-28
PCT/IB2002/003423 WO2003029220A2 (en) 2001-09-28 2002-08-22 Preparation of an anhydrous quinoline-based cetp inhibitor by crystallization

Publications (1)

Publication Number Publication Date
DK1503987T3 true DK1503987T3 (da) 2007-03-12

Family

ID=23270027

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02760459T DK1503987T3 (da) 2001-09-28 2002-08-22 Fremstilling af en vandfri quinolinbaseret CETP inhibitor ved krystallisering

Country Status (28)

Country Link
US (1) US6573383B2 (da)
EP (1) EP1503987B1 (da)
JP (1) JP2005505584A (da)
KR (1) KR100629828B1 (da)
CN (1) CN1289485C (da)
AR (1) AR037325A1 (da)
AT (1) ATE346842T1 (da)
BR (1) BR0212916A (da)
CA (1) CA2461686A1 (da)
CY (1) CY1105843T1 (da)
CZ (1) CZ2004415A3 (da)
DE (1) DE60216520T2 (da)
DK (1) DK1503987T3 (da)
ES (1) ES2275902T3 (da)
GT (1) GT200200170A (da)
HK (1) HK1072424A1 (da)
HU (1) HUP0501098A3 (da)
IL (1) IL160026A0 (da)
MX (1) MXPA04002882A (da)
MY (1) MY134349A (da)
PA (1) PA8553801A1 (da)
PE (1) PE20030688A1 (da)
PL (1) PL373611A1 (da)
PT (1) PT1503987E (da)
RS (1) RS12004A (da)
UY (1) UY27454A1 (da)
WO (1) WO2003029220A2 (da)
ZA (1) ZA200400438B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR200483700Y1 (ko) 2016-02-05 2017-06-14 이요한 젓갈제조용 위생용기

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
CO5271716A1 (es) * 1999-11-30 2003-04-30 Pfizer Prod Inc Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida

Also Published As

Publication number Publication date
BR0212916A (pt) 2004-10-13
US6573383B2 (en) 2003-06-03
ES2275902T3 (es) 2007-06-16
PA8553801A1 (es) 2003-07-28
JP2005505584A (ja) 2005-02-24
PL373611A1 (en) 2005-09-05
US20030065010A1 (en) 2003-04-03
HUP0501098A3 (en) 2008-02-28
AR037325A1 (es) 2004-11-03
EP1503987B1 (en) 2006-11-29
WO2003029220A2 (en) 2003-04-10
EP1503987A2 (en) 2005-02-09
UY27454A1 (es) 2003-06-30
MXPA04002882A (es) 2004-07-02
PT1503987E (pt) 2007-02-28
CY1105843T1 (el) 2011-02-02
WO2003029220A3 (en) 2004-11-11
ZA200400438B (en) 2005-03-30
CA2461686A1 (en) 2003-04-10
RS12004A (en) 2007-02-05
DE60216520T2 (de) 2007-06-06
HUP0501098A2 (en) 2007-11-28
PE20030688A1 (es) 2003-08-11
IL160026A0 (en) 2004-06-20
CN1612862A (zh) 2005-05-04
KR20040048906A (ko) 2004-06-10
GT200200170A (es) 2003-05-23
KR100629828B1 (ko) 2006-09-29
MY134349A (en) 2007-12-31
HK1072424A1 (en) 2005-08-26
DE60216520D1 (de) 2007-01-11
CN1289485C (zh) 2006-12-13
CZ2004415A3 (cs) 2004-12-15
ATE346842T1 (de) 2006-12-15

Similar Documents

Publication Publication Date Title
IS7007A (is) Kristallaform af asiþrómýsíni
DK1438306T3 (da) Derivater af UK-2A
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
DK1417180T3 (da) Fremstilling af aminopyrimidinforbindelser
DK1432707T3 (da) Azabicyklisk-substituerede kondenserede heteroarylforbindelser til behandling af sygdomme
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1132570T3 (da) Sammensætninger til syrebehandling af borebrönde
DK1401828T3 (da) N-Formylhydroxylaminforbindelser som inhibitorer af PDF
DK1487832T3 (da) Krystallinsk mikronisat af tiotropiumbromid
DK1458447T3 (da) Kombination af cytokrom-p450-beroende proteasinhibitorer
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
ID30465A (id) Mekanisme pengarah petransmisi daya selubung
DK1578731T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
DK1282596T3 (da) Fremstilling af iminodieddikesyreforbindelser ud fra monoethanolaminsubstrater
DK1377544T3 (da) Oprensning af 2-nitro-4-methylsulfonylbenzoesyre
ITRM20020555A0 (it) Forma cristallina anidra di cloridrato di valaciclovir.
DK1280803T3 (da) Krystallinsk form II af cabergolin
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DE60224712D1 (de) Fähigen silizidagglomerationsschmelzverbindung
IS7195A (is) Ný vatnsfrí kristallaform af gabapentíni
DK1503987T3 (da) Fremstilling af en vandfri quinolinbaseret CETP inhibitor ved krystallisering
DK1311679T3 (da) Fremgangsmåde til inhibering af IL-22-induceret PAP1
DK1373245T3 (da) Mellemprodukter til fremstilling af spinosyner